Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 066593/0902 | |
| Pages: | 7 |
| | Recorded: | 02/28/2024 | | |
Attorney Dkt #: | STANFORD TO CZB |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17620633
|
Filing Dt:
|
12/17/2021
|
Publication #:
|
|
Pub Dt:
|
11/17/2022
| | |
PCT #:
|
US2038526
|
Title:
|
BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18269237
|
Filing Dt:
|
06/22/2023
|
Publication #:
|
|
Pub Dt:
|
01/25/2024
| | | | |
Title:
|
BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T CELLS
|
|
Assignees
|
|
|
499 ILLINOIS STREET |
SAN FRANCISCO, CALIFORNIA 94158 |
|
|
|
OFFICE OF THE GENERAL COUNSEL |
BLDG. 170, MAIN QUAD |
STANFORD, CALIFORNIA 94305 |
|
Correspondence name and address
|
|
MARYANN KOSTIUK
|
|
KILPATRICK TOWNSEND & STOCKTON LLP
|
|
APT. 133
|
|
1302 EL CAMINO REAL | SUITE 175, CA 94025
|
Search Results as of:
09/23/2024 05:43 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|